ロード中...
Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation
BACKGROUND. Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease generally refractory to standard chemotherapeutic agents; therefore improvements in anticancer therapies are mandatory. A major determinant of therapeutic resistance in PDAC is the poor drug delivery to neoplastic cells, mainly...
保存先:
| 出版年: | Radiol Oncol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Versita, Warsaw
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4387991/ https://ncbi.nlm.nih.gov/pubmed/26029026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/raon-2015-0013 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|